The immune-inflamed profile, characterized by CD8+ and CD4+ tumor-infiltrating lymphocytes (TILs), and PD-L1 expression on immune and tumor cells, is classically associated with better response to ICI [58,59]. Here, CD8A is linked to neoplasm.